ACTIVAERO GMBH
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 01, 2014 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 205 Total Citation Count
- Jun 12, 2001 Earliest Filing
- 8 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0076,859 Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary DiseasesAbandonedSep 23, 10Mar 29, 12[A61K, C07C, A61P]
2010/0092,397 Method For Treatment of COPD and Other Pulmonary DiseasesAbandonedSep 30, 09Apr 15, 10[A61K, A61P]
2009/0178,672 METHODS, SYSTEMS AND COMPUTER-READABLE PRODUCTS FOR OPTIMIZING AEROSOL PARTICLE ADMINISTRATION TO THE LUNGSAbandonedDec 04, 08Jul 16, 09[A61B, A61M]
2009/0155,270 CASPASE INHIBITORS, ESPECIALLY CASPASE 3 INHIBITORS, FOR THE TREATMENT OF INFLUENZAAbandonedDec 10, 08Jun 18, 09[A61K, C12Q, C12N, A61P]
2007/0172,489 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenzaAbandonedMar 24, 04Jul 26, 07[A61K, C12Q]
2006/0247,161 Use of active ingredients for the prophylaxis and/or therapy of viral diseasesAbandonedJan 02, 04Nov 02, 06[A61K]
2005/0215,627 Application of substances acting as cascade inhibitors of the Raf/MEK/ERK signaling cascade for the production of a drug against DNA and RNA virusesAbandonedOct 21, 04Sep 29, 05[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.